FDA Announces Changes To ED Drug Labels

Law360, New York (October 19, 2007, 12:00 AM EDT) -- The U.S. Food and Drug Administration said Thursday that it has approved labeling changes for three popular erectile dysfunction drugs to better warn consumers about a possible risk of sudden hearing loss.

Pfizer Inc.'s Viagra, Eli Lilly & Co.'s Cialis, and Levitra, marketed jointly by Schering-Plough Corp. and GlaxoSmithKline Inc., already include warning labels for possible auditory side effects. The new labels will display a more prominent and specific warning about sudden hearing loss, and include new information for patients about what they should do if...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.